Regenerative Medicine & Peptide Therapeutics

October 18, 2026

Regenerative Medicine & Peptide Therapeutics is a one-day hybrid Continuing Medical Education (CME) activity presented by IRMN. This evidence-based educational program explores advances in regenerative medicine, peptide therapeutics, neuro-regeneration, musculoskeletal regenerative therapies, and emerging clinical applications. Through expert-led presentations and panel discussions, participants will critically evaluate current evidence, distinguish established therapies from investigational approaches, understand regulatory considerations, and integrate evidence-based regenerative medicine principles into clinical practice.

Target Audience

This activity is designed for an audience of psychiatrists, Neurologists, Orthopedic Surgeons, Internal Medicine Physicians, Family Medicine Physicians, Pain Medicine Physicians, Sports Medicine Physicians, Regenerative Medicine Physicians, Nurse Practitioners, Physician Assistants, and other healthcare professionals.

Learning Objectives

Describe current scientific evidence supporting regenerative medicine and peptide therapeutics
Evaluate appropriate clinical applications and limitations
⁠Differentiate evidence-based treatments from investigational interventions
⁠Apply current research findings to patient care
⁠⁠Discuss regulatory, ethical, and safety considerations

Commercial Support
There is no commercial support for this activity.

Course summary

Available credit:

6.00 AANP Contact Hours
Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Institute for Regenerative Medicine and Neuroscience. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 6.00 contact hour(s) (which includes 0.00 hour(s) of pharmacology).
6.00 AAPA Category 1 CME
Physician Associates
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
6.00 AMA PRA Category 1 Credit™
Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
6.00 ANCC Contact Hours
Nurses
Credit being awarded: 6.00 ANCC contact hours
6.00 AMA PRA Category 1 Credit™ Non-MD
Non-Physicians Seeking AMA Credit
AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens:

10/18/2026

Course expires:

11/18/2026

Event starts:

10/18/2026 - 9:00am EDT

Event ends:

10/18/2026 - 4:00pm EDT

Cost:

$0.00

Add to calendar:

Rating:

Institute for Regenerative Medicine and Neuroscience

Live Webinar

United States

All of the relevant financial relationships listed for these individuals have been mitigated.

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)